Rima Patel
@RimapatelMD
Followers
275
Following
425
Statuses
26
Breast Medical Oncologist @MountSinaiNYC @TischCancer
New York, NY
Joined February 2016
RT @rleonferre: 📣What is the role of immune activation on the prognosis of early #TNBC if chemo is not given? We evaluated ~ 2,000 pts w eT…
0
37
0
Excited to be staying at Mount Sinai as an Assistant Professor in Breast Medical Oncology! Thankful for the support of my incredible mentors, family, and friends. Looking forward to this next chapter!
14
3
119
RT @uroosaibrahim: Huge congratulations to @IcahnMountSinai @SinaiHemeOnc graduating fellows #2023 👏🎓🌟 Good luck on starting stellar career…
0
3
0
RT @matteolambe: Finally out in @NEJM results from #POSITIVE trial showing that temporary interruption of #EndocrineTherapy to attempt #pre…
0
188
0
Thank you @OncLive for the opportunity to share our findings on the relationship between race, Ki67, and Oncotype as well as palliative care use in elderly patients with breast cancer.
Thank you, @RimapatelMD, of @MountSinaiNYC, for stopping by at #SABCS to talk about racial disparities and elderly palliative care in breast cancer! Check out our site for the latest insights from @SABCSSanAntonio! #bcsm
1
4
35
RT @FauziaRiaz: #VailWorkshop reunion at #SABCS2022 —great fun catching up friends/colleagues (missing a few in the 📸!) @AACR @ASCO @SABCS…
0
4
0
RT @IcahnMountSinai: Our expert, @RimapatelMD will give poster presentations on her latest #BreastCancer research at #SABCS22. Be sure to v…
0
5
0
RT @SinaiHemeOnc: End-of-summer fellows & faculty picnic in Central Park replete with food, games, sun and camaraderie! 👏🏼 to our wellness…
0
4
0
RT @matteolambe: Updated results from #MONARCH3 at #ESMO22: addition of #abemaciclib to an aromatase inhibitor improves overall survival in…
0
74
0
RT @DrChoueiri: JUST IN: @GileadSciences announced statistically significant OS from Phase 3 TROPiCS-02: SG antibody-drug conjugate prolong…
0
61
0
Excited to share our work on the correlation between Oncotype and Ki67 using the IKWG categories. Important to consider when using Ki67 in clinical practice, especially to guide adjuvant abemaciclib @jsparano @MelanieKierMD @BZimmermanMD @TischCancer
The results of this study show no agreement between IHC-measured Ki67 using the International Ki67 Working Group prognostic groups & Oncotype DX Recurrence Score in patients with early #BreastCancer. @TischCancer @RimapatelMD @jsparano @OncoAlert
3
5
41
Wrapping up an incredible week of clinical trial development at @AACR @ASCO #MCCR. Grateful to be have met and worked with these amazing oncologists! @quirogad @rleonferre @gandhi_shipra @FauziaRiaz @JingJiMD @JMcGuinnessMD @tarekmd91 @sridevirajeeve @lwumd323
0
3
36
RT @sridevirajeeve: Representing @IcahnMountSinai @TischCancer @SinaiHemeOnc at the @AACR @ASCO #MCCR22 "Vail" workshop. What a phenomenal…
0
7
0
Enjoying our last day in #Vail for the @AACR @ASCO #MCCR workshop with these amazing women oncologists! @sridevirajeeve @KrithikaShanm @PrincessMark17
0
0
21
RT @DrDawnHershman: So proud of our PDG2 group @AACR @ASCO Vail #MCCR22 - Always an amazing experience, in an amazing place with amazing pe…
0
8
0
RT @alainajkessler: Beaming as I watch @laura_huppert present at #ASCO22 as a fellow! This is a big deal 🙌🏼
0
3
0
RT @TischCancer: .@RimapatelMD presented today at #ASCO22: Correlation of Ki67 working group prognostic risk categories with oncotype DX re…
0
1
0